{"result": "(\"entity\"<|>OSLAND E<|>PERSON<|>Osland E is an author involved in research related to peri-operative nutritional supplementation in patients undergoing pancreaticoduodenectomy.)\n##\n(\"entity\"<|>HOSSAIN MB<|>PERSON<|>Hossain MB is an author contributing to studies on the effects of pharmaconutrition in surgical outcomes for gastrointestinal malignancies.)\n##\n(\"entity\"<|>KHAN S<|>PERSON<|>Khan S is an author who has researched pancreatic cancer related cachexia and its impact on metabolism and weight loss.)\n##\n(\"entity\"<|>MEMON MA<|>PERSON<|>Memon MA is an author involved in the systematic review of nutritional interventions in pancreatic cancer surgery.)\n##\n(\"entity\"<|>BACHMANN J<|>PERSON<|>Bachmann J is an author who has conducted a meta-analysis on immune modulating nutrients in major open gastrointestinal surgery.)\n##\n(\"entity\"<|>KETTERER K<|>PERSON<|>Ketterer K is an author contributing to research on the effects of nutritional combinations on surgical outcomes.)\n##\n(\"entity\"<|>MARSH C<|>PERSON<|>Marsh C is an author involved in studies related to gastrointestinal cancer and nutritional interventions.)\n##\n(\"entity\"<|>FECHTNER K<|>PERSON<|>Fechtner K is an author who has researched the symptoms of exocrine pancreatic cancer and their relation to tumor site and stage.)\n##\n(\"entity\"<|>KRAKOWSKI-ROOSEN H<|>PERSON<|>Krakowski-Roosen H is an author who has studied the prevalence and outcomes of malnutrition in pancreatic surgery.)\n##\n(\"entity\"<|>BÜCHLER MW<|>PERSON<|>Büchler MW is an author involved in research on the effects of preoperative immunonutrition in pancreatic cancer patients.)\n##\n(\"entity\"<|>MASSACHUSETTS GENERAL HOSPITAL<|>ORGANIZATION<|>Massachusetts General Hospital is a medical institution where significant research on the Whipple procedure has been conducted.)\n##\n(\"entity\"<|>PANCREATIC CANCER<|>EVENT<|>Pancreatic cancer is a significant health issue that is the focus of various studies regarding nutritional interventions and surgical outcomes.)\n##\n(\"entity\"<|>GASTROINTESTINAL CANCER<|>EVENT<|>Gastrointestinal cancer encompasses various malignancies that are studied for their nutritional needs and surgical outcomes.)\n##\n(\"relationship\"<|>OSLAND E<|>MASSACHUSETTS GENERAL HOSPITAL<|>Osland E's research on nutritional supplementation is associated with studies conducted at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>HOSSAIN MB<|>MASSACHUSETTS GENERAL HOSPITAL<|>Hossain MB's work on pharmaconutrition is linked to research at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>KHAN S<|>MASSACHUSETTS GENERAL HOSPITAL<|>Khan S's studies on pancreatic cancer cachexia are related to research conducted at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>MEMON MA<|>MASSACHUSETTS GENERAL HOSPITAL<|>Memon MA's research on nutritional interventions is associated with studies at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>BACHMANN J<|>MASSACHUSETTS GENERAL HOSPITAL<|>Bachmann J's meta-analysis on immune modulating nutrients is linked to research at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>KETTERER K<|>MASSACHUSETTS GENERAL HOSPITAL<|>Ketterer K's work on nutritional combinations is associated with studies at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>MARSH C<|>MASSACHUSETTS GENERAL HOSPITAL<|>Marsh C's research on gastrointestinal cancer is linked to studies at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>FECHTNER K<|>MASSACHUSETTS GENERAL HOSPITAL<|>Fechtner K's studies on pancreatic cancer symptoms are related to research at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>KRAKOWSKI-ROOSEN H<|>MASSACHUSETTS GENERAL HOSPITAL<|>Krakowski-Roosen H's research on malnutrition in pancreatic surgery is associated with studies at Massachusetts General Hospital<|>7)\n##\n(\"relationship\"<|>BÜCHLER MW<|>MASSACHUSETTS GENERAL HOSPITAL<|>Büchler MW's work on preoperative immunonutrition is linked to research at Massachusetts General Hospital<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Systematic re-                     116.    Osland E, Hossain MB, Khan S, Memon MA.\n      view of peri-operative nutritional supplementa-                             Effect of timing of pharmaconutrition (immuno-\n      tion in patients undergoing pancreaticoduode-                               nutrition) administration on outcomes of elective\n      nectomy. JOP. 2006; 7(1):5-13.                                              surgery for gastrointestinal malignancies: a syste-\n104.  Bachmann J, Ketterer K, Marsch C, Fechtner K,                               matic review and meta-analysis. JPEN J Parenter\n      Krakowski-Roosen H, Büchler MW,                et al. Pan-                  Enteral Nutr. 2014; 38:53-69.\n      creatic cancer related cachexia: influence on me-                   117.    Marimuthu K, Varadhan KK, Ljungqvist O, Lobo\n      tabolism and correlation to weight loss and pul-                            DN. A meta-analysis of the effect of combina-\n      monary function. BMC Cancer. 2009; 9:255.                                   tions of immune modulating nutrients on outco-\n105.  Porta M, Fabregat X, Malats N, Guarner L, Carra-                            me in patients undergoing major open gastroin-\n      to A, de Miguel A, et al. Exocrine pancreatic can-                          testinal surgery. Ann Surg. 2012; 255:1060-8.\n      cer: symptoms at presentation and their relation                    118.    Zhang Y, Gu Y, Guo T, Li Y, Cai H. Perioperative\n      to tumour site and stage. Clin Transl Oncol.                                immunonutrition for gastrointestinal cancer: a\n      2005; 7:189-97.                                                             systematic     review     of   randomized       controlled\n106.  Bye A, Jordhøy MS, Skjegstad G, Ledsaak O, Iver-                            trials. Surg Oncol. 2012; 21:e87-95.\n      sen PO, Hjermstad MJ. Symptoms in advanced                          119.    Gade J, Levring T, Hillingsø J, Hansen CP, Ander-\n      pancreatic cancer are of importance for energy                              sen JR. The Effect of Preoperative Oral Immunonu-\n      intake. Support Care Cancer. 2013; 21:219-27.                               trition on Complications and Length of Hospital\n107.  La Torre M, Ziparo V, Nigri G, Cavallini M, Bal-                            Stay After Elective Surgery for Pancreatic Can-\n      ducci G, Ramacciato G. Malnutrition and Pan-                                cer--A Randomized Controlled Trial. Nutr Cancer.\n      creatic Surgery: Prevalence and Outcomes. J Surg                            2016; 68:225-33.\n      Oncol. 2013; 107:702-8.                                             120.    Martin RC 2nd, Agle S, Schlegel M, Hayat T, Sco-\n108.  Bossola M, Pacelli F, Tortorelli A, Doglietto GB.                           ggins    CR,   McMasters       KM,    et  al.  Efficacy    of\n      Cancer cachexia: it’s time for more clinical trials.                        preoperative immunonutrition in locally advan-\n      Ann Surg Oncol. 2007; 14:276-85.                                            ced   pancreatic     cancer    undergoing       irreversible\n109.  Ockenga J, Valentini L. Review article: anorexia                            electroporation (IRE). Eur J Surg Oncol. 2017. pii:\n      and cachexia in gastrointestinal cancer. Aliment                            S0748-7983(17)30046-X.\n      Pharmacol Ther. 2005; 22:583-94.                                    121.    Słotwiński R, Olszewski W, Słodkowski M, Lech\n110.  ernández-del Castillo C, Morales-Oyarvide V, Mc-                            G, Zaleska M, Kędziora S, et al. Apoptosis in lym-\n      Grath D, Wargo JA, Ferrone CR, Thayer SP, et al.                            phocytes of pancreatic cancer patients: influence\n      Evolution of the Whipple procedure at the Mas-                              of preoperative enteral immunonutrition and ex-\n      sachusetts General Hospital. Surgery. 2012 Sep;                             tensive surgery. Arch Immunol Ther Exp (Warsz).\n      152(3 Suppl 1):S56-63.                                                      2011; 59:385-97.\n111.  Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S,                      122.    Shirakawa H, Kinoshita T, Gotohda N, Takahashi\n      Nakao A. Nutritional predictors of postoperative                            S, Nakagohri T, Konishi M. Compliance with and\n      outcome in pancreatic cancer. Br J Surg. 2011;                              effects of preoperative immunonutrition in pa-\n      98:268-74.                                                                  tients undergoing pancreaticoduodenectomy. J\n112.  Lassen K, Coolsen MM, Slim K, Carli F, de Agui-                             Hepatobiliary Pancreat Sci. 2012; 19:249-58.\n      lar-Nascimento JE\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}